Alpa Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ALPA BSE: 532878

₹59.51

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #135 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Alpa Laboratories Limited (this stock)	125	28.3	6.3%	-33.0%	—	52	63	47

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹126 Cr

EV / EBITDA

14.7x

EV / Sales

1.13x

Market cap / Sales

1.13x

Earnings yield

3.53%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 30 Cr, down 4.2% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 1 Cr, down 91.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	24	1	1	₹0.5200
March 31, 2026	31	3	1	₹0.6400
Dec. 31, 2025	30	2	2	₹0.8900
Sept. 30, 2025	26	0	0	₹0.0500
June 30, 2025	19	12	12	₹5.6000
March 31, 2025	39	2	-2	₹-0.8600
Dec. 31, 2024	26	9	9	₹4.2350
Sept. 30, 2024	25	10	8	₹3.6300
June 30, 2024	21	5	5	₹2.4400
March 31, 2024	24	7	4	₹1.7000
Dec. 31, 2023	27	5	5	₹2.1500
Sept. 30, 2023	32	6	6	₹2.7500
June 30, 2023	25	3	3	₹1.4400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	30	31	30	29	31	42	35	32	27	28	31	35	30
Operating revenue	24	31	30	26	19	39	26	25	21	24	27	32	25
Other income	6	-0	0	4	12	3	9	7	5	4	4	3	4
Operating expenses	28	28	28	28	19	39	25	22	21	20	25	29	27
Operating profit	-4	4	2	-3	0	-0	1	3	1	4	2	3	-1
Operating profit margin	-16.5%	11.5%	7.2%	-11.2%	2.2%	-0.9%	2.8%	13.1%	2.5%	14.9%	9.0%	10.2%	-4.5%
Depreciation	1	0	1	1	1	1	1	1	1	1	1	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	0	0	0	—	0
Profit before tax	1	3	2	0	12	2	9	10	5	7	5	6	3
Tax	—	2	-0	—	—	4	—	2	—	3	1	—	—
Net profit	1	1	—	0	12	-2	9	8	5	4	5	6	3
EPS	0.52	0.64	0.89	0.05	5.60	-0.86	4.24	3.63	2.44	1.70	2.15	2.75	1.44
Net profit (TTM)	—	—	—	19	26	20	25	21	19	17	18	19	13
EPS (TTM)	2.10	7.18	5.68	9.03	12.61	9.45	12.01	9.92	9.04	8.04	8.43	8.73	6.08

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	106	17	15
March 31, 2025	112	26	20
March 31, 2024	109	21	17
March 31, 2023	92	16	13

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	5.9%	3.6%	122^†	136^†	124^†	102^†	125^†	102^†	89^†	83^†	65^†	72^†
Operating revenue	4.6%	1.6%	106	112	109	92	113^†	98^†	86^†	78^†	61^†	66^†
Other income	—	—	16^†	24^†	15^†	10^†	13^†	4^†	3^†	5^†	4^†	6^†
Operating expenses	—	—	103^†	107^†	101^†	85^†	104^†	90^†	83^†	77^†	57^†	57^†
Operating profit	-24.1%	-15.6%	3^†	4^†	8^†	8^†	8^†	8^†	3^†	1^†	4^†	8^†
Operating profit margin	—	—	3.1%^†	3.8%^†	7.5%^†	8.2%^†	7.5%^†	7.9%^†	4.0%^†	1.4%^†	6.8%^†	12.6%^†
Depreciation	—	—	2^†	2^†	2^†	1^†	2^†	1^†	1^†	1^†	1^†	1^†
Interest	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	1^†	1^†	2^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	-2^†
Profit before tax	1.5%	9.0%	17	26	21	16	19^†	11^†	5^†	4^†	6^†	9^†
Tax	—	—	—	—	—	—	—	—	—	—	—	—
Net profit	5.8%	15.5%	15	20	17	13	14^†	7^†	4^†	3^†	5^†	6^†
EPS	6.7%	5.9%	7.18^†	9.45^†	8.04^†	5.91^†	6.63^†	5.39^†	1.95^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	3.1%^†	3.8%^†	7.5%^†	8.2%^†	7.5%^†	7.9%^†	4.0%^†	1.4%^†	6.8%^†	12.6%^†
EBIT margin	16.0%^†	23.4%^†	19.4%^†	17.5%^†	17.5%^†	11.2%^†	6.1%^†	6.4%^†	12.3%^†	15.9%^†
PBT margin	15.7%	23.1%	19.0%	17.2%	17.2%^†	11.1%^†	5.9%^†	5.7%^†	10.5%^†	13.3%^†
Net margin	14.1%	17.6%	15.4%	13.7%	12.4%^†	7.4%^†	4.7%^†	3.8%^†	7.6%^†	8.8%^†
Interest coverage	57.95x^†	98.03x^†	54.11x^†	72.32x^†	76.48x^†	110.90x^†	26.45x^†	8.97x^†	7.14x^†	6.07x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	4.06x	4.08x	—	—	—	—	—	—	—	—
Quick ratio	3.80x	3.70x	—	—	—	—	—	—	—	—
Debt to equity	0.01x	0.00x	—	—	—	—	—	—	—	—
Return on equity	7.6%	10.8%	—	—	—	—	—	—	—	—
Return on assets	5.9%	8.4%	—	—	—	—	—	—	—	—
Return on capital employed	8.5%^†	14.0%^†	—	—	—	—	—	—	—	—
Asset turnover	0.42x	0.48x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	11	-12	-1	4	8
March 31, 2025	18	-12	-6	11	7
March 31, 2024	4	-13	2	6	-3
March 31, 2023	-5	1	-3	1	-6
March 31, 2022	-2	-16	6	2	-4

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	251	197	176	2	0	209	51	1	20	13
March 31, 2025	233	182	161	0	0	190	47	0	21	18
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.